PFG Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
PFG Advisors's BMY Position: Q2 2026 in Review
PFG Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 5,331 shares — an estimated $323K sold.
PFG Advisors first reported a position in BMY in Q1 2020 and held it in 23 quarters. The position peaked at $674K in Q4 2022. 852 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- PFG Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- PFG Advisors sold 5,331 Bristol-Myers Squibb shares in Q2 2026, an estimated $323K.
- PFG Advisors first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 23 quarters.
- PFG Advisors's Bristol-Myers Squibb position peaked at $674K in Q4 2022.
- 852 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.